This suggests that liraglutide regulates both the ACE/Ang II/AT1R axis and the ACE2/Ang1-7/Mas axis under NAFLD conditions, both in vivo and in vitro. The gene discussed is MAS1; the disease is metabolic dysfunction-associated steatotic liver disease.